Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01988766 · ClinicalTrials.gov registry record

Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement

A clinical trial of Thrombosis, sponsored by University of Chicago.

Completed
Registry status
1,424
Enrollment target
1
Study location

NCT01988766 is a study of Thrombosis that has completed, run by University of Chicago. The registered enrollment target is 1,424 participants, above the 419-participant average among 28 other Thrombosis trials with a reported enrollment target (240% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01988766, a study of Thrombosis, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
1,424 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the difference in thrombosis as a result of internal jugular (IJ) catheters versus peripherally inserted central catheter (PICC) lines. It is hypothesized that there will be a decreased rate of thrombosis in patients as a result of IJ catheters verses PICC lines.

Conditions Studied

Thrombosis

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 1,424 participants
Start Date 2012-10
Est. Completion 2014-08

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01988766

The ClinicalTrials.gov registry entry for NCT01988766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,424 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 419-participant average among 28 other Thrombosis trials with a reported enrollment target (240% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thrombosis appearing as the primary indexed condition, and to 0 interventions.

NCT01988766 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01988766 about?

NCT01988766 is a clinical study titled "Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement". The purpose of this study is to compare the difference in thrombosis as a result of internal jugular (IJ) catheters versus peripherally inserted central catheter (PICC) lines. It is hypothesized that there will be a decreased rate of thrombosis in patients as a result of IJ catheters verses PICC lin...

What is the current status of trial NCT01988766?

This trial is currently completed. The enrollment target is 1,424 participants. The study started on 2012-10. Estimated completion is 2014-08.

What conditions does trial NCT01988766 study?

This clinical trial studies the following conditions: Thrombosis.

Who is sponsoring clinical trial NCT01988766?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01988766 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Thrombosis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.